Screening for hepatitis B and C in first-generation Egyptian migrants living in the Netherlands

Liver International

Volumn 33, Issue 5, 2013, Pages 727-738

  Zuure, Freke R ^a   Bouman, Jonathan ^a,b   Martens, Marjolein ^a   Vanhommerig, Joost W ^a   Urbanus, Anouk T ^a,b   Davidovich, Udi ^a   van Houdt, Robin ^a   Speksnijder, Arjen G C L ^a   Weegink, Christine J ^b   van den Hoek, Anneke ^a,b   Prins, Maria ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Community based screening; Egypt; First generation migrants; HBV; HCV

Indexed keywords

ANTISCHISTOSOMAL AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGE; ANTIMICROBIAL THERAPY; ARTICLE; EGYPT; FEMALE; FOLLOW UP; GENOTYPE; GEOGRAPHIC ORIGIN; HEPATITIS B; HEPATITIS C; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NETHERLANDS; NUCLEOTIDE SEQUENCE; PHYLOGENY; SCREENING;

ANTIBODIES, VIRAL; BASE SEQUENCE; EGYPT; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LOGISTIC MODELS; MASS SCREENING; MOLECULAR SEQUENCE DATA; NETHERLANDS; PHYLOGENY; PREVALENCE; QUESTIONNAIRES; SEQUENCE ANALYSIS, DNA; TRANSIENTS AND MIGRANTS;

EID: 84876090528     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12131     Document Type: Article

References (42)

1. World Health Organization. Hepatitis B Fact sheet No. 204, July 2012. Available online at http://www.who.int/mediacentre/factsheets/fs204/en/. Accessed: 2 August 2012.
2. Perz JF, Farrington LA, Pecoraro C, Hutin YJ, Armstrong GL. Estimated global prevalence of hepatitis C virus infection. 42nd Annual meeting of the infectious diseases society of America, Boston, MA. September 30-October 3, 2004.
3. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-58.
4. Sievert W, Altraif I, Razavi HA, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011; 31(Suppl. 2): 61-80.
5. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
6. Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, van den Hoek JA. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol 2007; 79: 1802-10.
7. Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011; 31(Suppl. 2): 30-60.
8. Vriend HJ, Op de Coul EL, van de Laar TJ, et al. Hepatitis C virus seroprevalence in The Netherlands. Eur J Public Health 2012; 22: 819-21.
9. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.
10. Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR 2008; 57: 1-20.
11. Zohry A, Debnath P. A Study on the Dynamics of the Egyptian Diaspora: Strenghtening Development Linkages. Cairo, Egypt: International Organisation for Migration (IOM), 2010.
12. Dore GJ, Matthews GV, Rockstroh J. Future of hepatitis C therapy: development of direct-acting antivirals. Curr Opin HIV AIDS 2011; 6: 508-13.
13. Tujios SR, Lee WM. New advances in chronic hepatitis B. Curr Opin Gastroenterol 2012; 28: 193-7.
14. Zohry A. The Migratory Patterns of Egyptians in Italy and France, CARIM Research Reports 2009/17, Robert Schuman Centre for Advanced Studies. San Domenico di Fiesole (FI): European University Institute, 2009.
15. van de Laar TJ, Koppelman MH, van der Bij AK, et al. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands. Transfusion 2006; 46: 1719-28.
16. van Houdt R, Bruisten SM, Koedijk FD, et al. Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey. J Med Virol 2007; 79: 895-901.
17. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-73.
18. van de Laar TJ, Molenkamp R, van den Berg C, et al. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J Hepatol 2009; 51: 667-74.
19. de Bruijne J, Schinkel J, Prins M, et al. Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol 2009; 47: 3832-8.
20. van Asten L, Verhaest I, Lamzira S, et al. Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. J Infect Dis 2004; 189: 292-302.
21. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005; 21: 379-84.
22. van Houdt R, van den Berg CH, Stolte IG, et al. Two decades of hepatitis B infections among drug users in Amsterdam: are they still a high-risk group? J Med Virol 2009; 81: 1163-9.
23. van Houdt R, Bruisten SM, Geskus RB, et al. Ongoing transmission of a single hepatitis B virus strain among men having sex with men in Amsterdam. J Viral Hepat 2010; 17: 108-14.
24. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93.
25. Newcombe RG. Confidence intervals for a binomial proportion. Stat Med 1994; 13: 1283-5.
26. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2009.
27. Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med 2002; 21: 2409-19.
28. Koedijk FDH, Op de Coul ELM, Cremer J. Incidence and molecular epidemiology of hepatitis B virus, the Netherlands, 2004-2007. RIVM Briefrapport 210011001/2008.
29. Uddin G, Shoeb D, Solaiman S, et al. Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat 2010; 17: 327-35.
30. Veldhuijzen IK, van Driel HF, Vos D, et al. Viral hepatitis in a multi-ethnic neighborhood in the Netherlands: results of a community-based study in a low prevalence country. Int J Infect Dis 2009; 13: e9-13.
31. Urbanus AT, van de Laar TJ, van den Hoek A, et al. Hepatitis C in the general population of various ethnic origins living in the Netherlands: should non-Western migrants be screened? J Hepatol 2011; 55: 1207-14.
32. Richter C, Beest GT, Sancak I, et al. Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policy? Epidemiol Infect 2012; 140: 724-30.
33. Khlat M, Darmon N. Is there a Mediterranean migrants mortality paradox in Europe? Int J Epidemiol 2003; 32: 1115-8.
34. Nassar H. Migration, Transfers and Development in Egypt, Research Reports, CARIM-RR 2005/01. Florence: European University Institute, Robert Schuman Centre for Advanced Studies, 2005.
35. Makhlouf HH, Gaafar MS, Ahmed FA, et al. Push and Pull Factors of International Migration: Country Report for Egypt. Luxembourg: Eurostat, European Communities, 2000.
36. Ham A. Egyptians. In: Jupp J, ed. The Australian People. An Encyclopedia of the Nation, Its People and Their Origins, 2nd edn. Cambridge, UK: Cambridge University Press, 2001; 274-5.
37. Mostafa A, Taylor SM, El-Daly M, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int 2010; 30: 560-6.
38. Paez JA, Sharaf EN, Rimlinger F, et al. HCV iatrogenic and intrafamilial transmission in Greater Cairo. Egypt. Gut 2010; 59: 1554-60.
39. Bouwman-Notenboom AJ, van Diemen AJ, van Heerwaarden A, Schout C. China onder de Dom. Hepatitis B- en C-screening bij Chinese migranten in Utrecht. Infectieziekten Bulletin 2012; 23: 19-21.
40. Coffin PO, Scott JD, Golden MR, Sullivan SD. Cost-effectiveness and population outcomes of general population screening for hepatitis C. Clin Infect Dis 2012; 54: 1259-71.
41. Miners A, Ghosh A, Martin N, Vickerman P. An economic evaluation of finding cases of hepatitis B and C infection in UK migrant populations. London School of Hygiene & Tropical Medicine. 2012 Available at http://www.nice.org.uk/guidance/index.jsp?action=download&o=59551. Accessed: 27 July 2012.
42. Veldhuijzen IK, Toy M, Hahne SJ, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology 2010; 138: 522-30.